Savvy Update, 1/20/25: Glucagon RXs UP … BUT, Gut Bacterium Helps Cut Sugar Cravings, FDA Bans Red Dye, Red Meat Increases Dementia Risk, Empathy-Focused Calls Boost Self-Care, FTC 2nd Report Slams PMBs, BG Levels Pasta/Pizza Spike More in America, California Insulin Delayed, Ozempic Picked for Medicare Price Reduction, Adam Brown on Self-Talk & Juggling, Clinical Trial T1D & CKD, Omnipod Next-Gen?

Savvy Update, 1/20/25: Glucagon RXs UP … BUT, Gut Bacterium Helps Cut Sugar Cravings, FDA Bans Red Dye, Red Meat Increases Dementia Risk, Empathy-Focused Calls Boost Self-Care, FTC 2nd Report Slams PMBs, BG Levels Pasta/Pizza Spike More in America, California Insulin Delayed, Ozempic Picked for Medicare Price Reduction, Adam Brown on Self-Talk & Juggling, Clinical Trial T1D & CKD, Omnipod Next-Gen?

Jan 20, 2025 | Advocacy, Diabetes Business, Featured, Foods, Research News, Technology Updates, Videos

LOTS to READ in this week’s issue of The Savvy Diabetic:  Glucagon Prescriptions are UP … BUT Fall Short of Meeting Demand Special Gut Bacterium Could Help Cut Sugar Cravings FDA bans controversial red dye Processed Red Meat Increases Dementia Risk...
Savvy Updates, 1/13/25: Sana Islet Cell Transplants w/out Immunosuppression, Beta Bionics Files IPO, Glooko/Hedia Launches D Management Tech, CeQur $$ for Simplicity Patch Pump, Glucose Monitoring with Sweat, Medical Debt Removed from Credit, Coffee Best in AM

Savvy Updates, 1/13/25: Sana Islet Cell Transplants w/out Immunosuppression, Beta Bionics Files IPO, Glooko/Hedia Launches D Management Tech, CeQur $$ for Simplicity Patch Pump, Glucose Monitoring with Sweat, Medical Debt Removed from Credit, Coffee Best in AM

Jan 13, 2025 | Advocacy, Featured, Foods, Research News, Technology Updates

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression released by Sana.com, 7 January 2025. Sana Biotechnology, Inc., a company focused on changing the possible for patients through...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder

Sep 14, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates

Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely

Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely

Sep 3, 2024 | Diabetes Business, Exercise, Featured, Foods, Research News, Technology Updates

Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024. Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89...
Savvy Updates 8/19/24: Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED

Savvy Updates 8/19/24: Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED

Aug 19, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates, Videos

Tandem warns iPhone app still draining insulin pump batteries by Elise Reuter for MedTechDive.com, 15 August 2024. Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected...
Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Jun 3, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates

The Modular Medical MODD1 insulin pump. What do we know? by Tim Street for Diabettech.com, 31 May 2024. Modular Medical recently submitted their new pump system to the FDA for approval. It’s described as: “Effortless Insulin Delivery Made Possible.”...
Skip to content